It is therefore necessary to raise awareness of COPD-related AATD, and these results reinforce the need for genetic study and/or measurement of serum AAT levels in patients diagnosed with COPD here in Colombia. This evidence concerns the gene SERPINA1 and alpha 1-antitrypsin deficiency.